Viridian Therapeutics, Inc.\DE — Balance Sheet Charts
9 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+21.1% +$157M
$899M
Current Assets↑+21.1% +$156M
$894M
Cash & Equivalents↑+21.9% +$157M
$875M
ST Investments
—
Receivables
—
Inventory
—
Net PPE↓-0.6% -$8K
$1M
Total Liabilities↑+150.5% +$106M
$177M
Current Liabilities↑+47.7% +$23M
$71M
Account Payables↑+305.2% +$7M
$9M
Long-Term Debt↑+1.8% +$367K
$21M
Stockholders Equity↑+7.5% +$51M
$722M
Retained Earnings↓-34.4% -$343M
$-1.34B
Operating Lease ROU Asset↑+9.8% +$216K
$2M
Operating Lease Liability↑+428.7% +$2M
$3M
Gross PP&E↓-2.3% -$58K
$2M
Accumulated Depreciation↓-3.9% -$50K
$1M
Debt Due Y1
—
Debt Due Y2
—
Debt Due Y3
—
Debt Due Y4
—
Total Debt Carrying Amount
$20M
Contract Asset↑+499900.0% +$70M
$70M
Contract Liability↓-35.8% -$205K
$367K
Contract Liability (Current)↑+27.4% +$79K
$367K
Contract Liability (Noncurrent)↓-67.3% -$288K
$140K